التفاصيل البيبلوغرافية
| العنوان: |
Venous thromboembolism and hyperhomocysteinemia as first manifestation of pernicious anemia: a case series. |
| المؤلفون: |
Ammouri, W., Tazi, Z., Harmouche, H., Maamar, M., Adnaoui, M., Tazi, Z Mezalek |
| المصدر: |
Journal of Medical Case Reports; 9/2/2017, Vol. 11 Issue 1, p1-5, 5p |
| مصطلحات موضوعية: |
HYPERHOMOCYSTEINEMIA, VENOUS thrombosis, PERNICIOUS anemia, ANTITHROMBIN III, CASE-control method, META-analysis, PERNICIOUS anemia diagnosis, PERNICIOUS anemia treatment, THROMBOEMBOLISM treatment, TREATMENT of hyperhomocysteinemia, ANTICOAGULANTS, FOLIC acid, VITAMIN deficiency, GASTRIC mucosa, IMMUNOGLOBULINS, CASE studies, THROMBOEMBOLISM, VEINS, VITAMIN B12, VITAMINS, TREATMENT effectiveness, DISEASE complications, DIAGNOSIS |
| مستخلص: |
Background: Hyperhomocysteinemia has been suspected of favoring thrombosis. Several case-control studies and even a meta-analysis have confirmed a link between venous thrombosis and hyperhomocysteinemia. Homocysteine is due to genetic and acquired factors (poor diet in folate and vitamin B12, older age, renal impairment, thyroid diseases, and malignancies) induced by the intake and the concentrations of vitamin B9 or B12 in the majority of cases.Cases Presentation: We report the cases of four Moroccan patients who presented with acute vein thrombosis of different sites: a 34-year-old man, a 60-year-old man, a 58-year-old man, and a 47-year-old woman. All patients had a low level of cobalamin with marked hyperhomocysteinemia with normal serum and red cell folic acid. Venous thrombosis revealed pernicious anemia in all patients. Their low levels of cobalamin, atrophic gastritis, and positive results for gastric parietal cell antibodies confirmed the diagnosis of pernicious anemia. There was no evidence of immobilization, recent surgery, malignancy, antiphospholipid antibody, myeloproliferative disorder, or hormone replacement therapy. No deficiencies in protein C and protein S were detected; they had normal antithrombin III function and factor V Leiden; no prothrombin gene mutations were detected. Treatment included orally administered anticoagulation therapy and cobalamin supplementation. The outcome was favorable in all cases.Conclusions: These reports demonstrate that pernicious anemia, on its own, can lead to hyperhomocysteinemia that is significant enough to lead to thrombosis. Understanding the molecular pathogenesis of the development of thrombosis in patients with hyperhomocysteinemia related to Biermer disease would help us to identify patients at risk and to treat them accordingly. The literature concerning the relationship between homocysteine and venous thrombosis is briefly reviewed. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Medical Case Reports is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Find this article in full text from Springer Verlag. 
Full Text Finder